Announce Date | 02/29/2024 |
EPS Normalized Actual | $2.72 (Beat by $0.21) |
EPS GAAP Actual | $2.72 (Beat by $0.21) |
Revenue Actual | $10.647B |
Revenue Surprise | Beat by $10647M |
Announce Date | 04/29/2024 (Pre-Market) |
EPS Normalized Estimate | $1.57149 |
EPS GAAP Estimate | $1.57149 |
Revenue Estimate | $16.752915546B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2029 | 11.63 | 6.33 | 11.2544 | 12.0656 | 2 |
Feb 2028 | 9.53 | 7.73 | 9.22222 | 9.88695 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.5 | 1.5 | 10.647B | -9.3% | 10647M |
FQ1 2022 (Jan 2022) | 2.65 | 2.65 | 16.365B | -3.5% | 16365M |
FQ4 2021 (Oct 2021) | 2.02 | 2.02 | 11.91B | 0.48% | 11910M |
FQ3 2021 (Jul 2021) | 2.93 | 2.93 | 11.849B | 16.36% | 11849M |
FQ2 2021 (May 2021) | 2.35 | 2.35 | 11.637B | 26.42% | 11637M |
FQ1 2021 (Jan 2021) | 3.15 | 3.15 | 16.937B | 10.28% | 16937M |
FQ4 2020 (Oct 2020) | 1.5 | 1.5 | 11.853B | 17.62% | 11853M |
FQ3 2020 (Aug 2020) | 1.67 | 1.67 | 9.91B | 3.77% | 9910M |
FQ4 Announce Date
04/29/2024 (Pre-Market)
Consensus EPS Estimates
1.57149
Consensus Revenue Estimates
16.752915546B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Nov 2025) | 1.65565 | -- | 1.62806 | 1.70207 | 7 |
FQ3 2025 (Aug 2025) | 1.4622 | -- | 1.43784 | 1.5032 | 7 |
FQ2 2025 (May 2025) | 1.21415 | -- | 1.19392 | 1.24819 | 7 |
FQ4 2024 (Oct 2024) | 1.53737 | -- | 1.43373 | 1.64389 | 15 |
FQ3 2024 (Jul 2024) | 1.33835 | -- | 1.24812 | 1.43108 | 16 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Nov 2025) | 10.32B | -- | 10.18B | 10.54B | 6 |
FQ3 2025 (Aug 2025) | 9.63B | -- | 9.5B | 9.83B | 11 |
FQ2 2025 (May 2025) | 9.26B | -- | 9.14B | 9.46B | 6 |
FQ4 2024 (Oct 2024) | 21.56B | -- | 19.68B | 23.33B | 12 |
FQ3 2024 (Jul 2024) | 19.17B | -- | 17.5B | 20.74B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.5 | 1.5 | 100% | |
FQ1 2022 (Jan 2022) | 2.65 | 2.65 | 100% | |
FQ4 2021 (Oct 2021) | 2.02 | 2.02 | 100% | |
FQ3 2021 (Jul 2021) | 2.93 | 2.93 | 100% | |
FQ2 2021 (May 2021) | 2.35 | 2.35 | 100% | |
FQ1 2021 (Jan 2021) | 3.15 | 3.15 | 100% | |
FQ4 2020 (Oct 2020) | 1.5 | 1.5 | 100% | |
FQ3 2020 (Aug 2020) | 1.67 | 1.67 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $10.65B | $10647M | 100% |
FQ1 2022 (Jan 2022) | $0B | $16.37B | $16365M | 100% |
FQ4 2021 (Oct 2021) | $0B | $11.91B | $11910M | 100% |
FQ3 2021 (Jul 2021) | $0B | $11.85B | $11849M | 100% |
FQ2 2021 (May 2021) | $0B | $11.64B | $11637M | 100% |
FQ1 2021 (Jan 2021) | $0B | $16.94B | $16937M | 100% |
FQ4 2020 (Oct 2020) | $0B | $11.85B | $11853M | 100% |
FQ3 2020 (Aug 2020) | $0B | $9.91B | $9910M | 100% |